Edition:
United Kingdom

Affimed NV (AFMD.OQ)

AFMD.OQ on NASDAQ Stock Exchange Global Market

2.78USD
3:38pm BST
Change (% chg)

$-0.14 (-4.64%)
Prev Close
$2.91
Open
$2.90
Day's High
$2.90
Day's Low
$2.75
Volume
63,294
Avg. Vol
173,538
52-wk High
$7.35
52-wk Low
$1.45

About

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body's own immune system to fight tumor cells. Its... (more)

Overall

Beta: 2.81
Market Cap(Mil.): $181.56
Shares Outstanding(Mil.): 62.39
Dividend: --
Yield (%): --

Financials

  AFMD.OQ Industry Sector
P/E (TTM): -- 105.08 37.43
EPS (TTM): -0.17 -- --
ROI: -13.94 7.78 12.14
ROE: -19.44 8.33 17.05

Earnings vs. Estimates